Open AccessBudget impact analysis ofCYP2C19-guided voriconazole prophylaxis in AML
Author(s) -
Neil Mason,
Gillian C. Bell,
Rod Quilitz,
John N. Greene,
Howard L. McLeod
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv224
Subject(s) - voriconazole , cyp2c19 , medicine , intensive care medicine , antifungal , cytochrome p450 , dermatology , metabolism
The objective of this study was to determine the economic impact of proactive, CYP2C19 genotype-guided voriconazole prophylaxis in AML.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom